Bibliography
- Neutel JM, Littlejohn TW, Chrysant SG, Singh A. Telmisartan/hydrochlorothiazide in comparison with losartan/hydrochlorothiazide in managing patients with mild-to-moderate hypertension. Hypertens Res 2005;28:555-63
- Lacourciere Y, Gil-Extremera B, Mueller O, et al. Efficacy and tolerability of fixed-dose combinations of telmisartan plus HCTZ compared with losartan plus HCTZ in patients with essential hypertension. Int J Clin Pract 2003;57(4):273-9
- Japanese Society of Hypertension Guidelines Committee. Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004). Hypertens Res 2006;29(Suppl):S1-105
- Chobanian AV, Bakris GL, Black HR, et al. The 7th report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure: The JNC 7 report. JAMA 2003;289:2560-72
- European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension–European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-53
- Whitworth JA. World Health Organization. International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on the management of hypertension. J Hypertens 2003;21(11):1983-92
- Minami J, Abe C, Akashiba A, et al. Long-term efficacy of combination therapy with losartan and low-dose hydrochlorothiazide in patients with uncontrolled hypertension. Int Heart J 2007;48:177-86
- Saruta T, OgiHara T, Matsuoka H et al. Antihypertensive efficacy and safety of fixed dose combination therapy with losartan plus hydrochlorothiazide in Japanese patients with essential hypertension. Hypertens Res 2007;30:729-39
- Kjeldsen SE, Os I, Hoieggen A, et al. Fixed-dose combinations in the management of hypertension: defining the place of angiotensin receptor antagonists and hydrochlorothiazide. Am J Cardiovasc Drugs 2005;5(1):17-22
- Pareek A, Karnik N, Salagre S, et al. Clinical effectiveness of low-dose chlorthalidone (6.25mg) + atenolol combination in stage I hypertensive patients: a multicenter, randomized, controlled study. Curr Med Res Opin 2008;24(6):1771-9
- Carter BL, Ernst ME, Cohen JD. Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability. Hypertension 2004;43(1):4-9
- Ernst ME, Carter BL, Goerdt CJ, et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 2006;47(3):352-8